Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Neoplasms × nilotinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Neoplastic Processes 1 Myeloproliferative Disorders 1 Leukemia 1 Hematologic Diseases 1 Bronchiolitis Obliterans Syndrome 1 Bone Marrow Diseases 1

Interventions

trametinib 3 encorafenib 3 dabrafenib 3 Oxaliplatin 3 zolbetuximab 2 selpercatinib 2 pembrolizumab 2 lenvatinib 2 larotrectinib 2 binimetinib 2 Leucovorin 2 Fulvestrant 2 Fluorouracil 2 Cetuximab 2 Capecitabine 2 trastuzumab deruxtecan 1 tepotinib 1 telisotuzumab vedotin 1 ribociclib 1 repotrectinib 1 relatlimab 1 pralsetinib 1 pegaspargase 1 niraparib 1 dostarlimab 1 blinatumomab 1 avelumab 1 asparaginase erwinia chrysanthemi recombinant 1 adagrasib 1 Vemurafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡